MedTrace Logo

Philips Intracardiac Echocardiography (ICE) Clinical Registry

NCT04950192 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2025-01-06

Study results available
· View outcomes & findings →

Summary

The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.

Conditions

  • Atrial Fibrillation
  • Stroke
  • Valve Disease, Heart
  • Atrial Septal Defect
  • Patent Foramen Ovale
  • Mitral Valve Disease
  • Tricuspid Valve Disease
  • Aortic Valve Disease

Interventions

DEVICE

ICE Image guidance

ICE image guidance will be used on all patients undergoing planned cardiac catheterization procedures

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Rashmi Ram, PhD · Philips Clinical and Medical Affairs

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-25
Primary Completion
2022-12-30
Completion
2023-07-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04950192 on ClinicalTrials.gov